NFATC2::NUTM2A/B Fusions Characterize a Novel Indolent Myoepithelial‐Like Neoplasm of the Lungs and Salivary Glands
Open Access
- 13 September 2025
- journal article
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 64 (9) , e70083
Abstract
With the increasing use of next‐generation sequencing, the classification of heretofore unclassified neoplasms is evolving rapidly. Specifically, gene fusions have emerged as context‐specific defining genetic markers for an increasing number of entities, mostly of soft tissue, bone, and salivary gland origin. We describe four myoepithelial‐like neoplasms of salivary (two) and pulmonary (two) origin, carrying recurrent NFATC2 fusions involving NUTM2B (three) and NUTM2A (one) as fusion partners. Patients were two females and two males aged 24–67 years (median, 33). The tumor size ranged from 1 to 4.5 cm. Treatment was surgery without (three) or with (one) adjuvant radiochemotherapy. No metastases or other primary tumors were found at the time of diagnosis. Three patients with follow‐up (two with salivary, one with pulmonary tumor) were disease‐free at 9, 11, and 31 months. Original diagnoses were “unclassified neoplasm” with consideration of adamantinoma‐like Ewing sarcoma and myoepithelial neoplasm. Histology revealed infiltrating monotonous epithelioid to basaloid cells arranged into lobular aggregates, nests, and cords within variably sclerosed stroma containing extensive basement membrane‐like hyaline material. Frankly malignant features (malignant cytology, high mitotic activity, necrosis, perineural or lymphovascular invasion) were absent. IHC showed coexpression of low and high molecular weight keratins (AE1/AE3 and CK5/6; 4/4), EMA (2/2), and CD99 (2/2). Negative markers included p63 (0/4), NUT (0/4), S100 (0/4), SOX10 (0/4), p40 (0/2), and SMA (0/2). This study introduces a novel salivary and lung tumor entity driven by NFATC2::NUTM2A/B fusions and displaying myoepithelial‐like morphology but imperfect myoepithelial immunophenotype. Report of more cases should shed light on the biological properties and appropriate therapeutic strategies of this novel neoplasm.Keywords
This publication has 17 references indexed in Scilit:
- FUS-NFATC2 or EWSR1-NFATC2 Fusions Are Present in a Large Proportion of Simple Bone CystsAmerican Journal of Surgical Pathology, 2020
- The clinical heterogeneity of round cell sarcomas with EWSR1/FUS gene fusions: Impact of gene fusion type on clinical features and outcomeGenes, Chromosomes and Cancer, 2020
- NFATc2-rearranged sarcomas: clinicopathologic, molecular, and cytogenetic study of 7 cases with evidence of AGGRECAN as a novel diagnostic markerLaboratory Investigation, 2020
- YWHAE-NUTM2A/B Translocated High-grade Endometrial Stromal Sarcoma Commonly Expresses CD56 and CD99International Journal of Gynecological Pathology, 2019
- EWSR1/FUS-NFATc2 rearranged round cell sarcoma: clinicopathological series of 4 cases and literature reviewHuman Pathology, 2019
- EWSR1-NFATC2 gene fusion in a soft tissue tumor with epithelioid round cell morphology and abundant stroma: a case report and review of the literatureHuman Pathology, 2018
- NUTM2A-CIC fusion small round cell sarcoma: a genetically distinct variant of CIC-rearranged sarcomaHuman Pathology, 2017
- An Unusual Case of YWHAE-NUTM2A/B Endometrial Stromal Sarcoma With Confinement to the Endometrium and Lack of High-Grade MorphologyInternational Journal of Gynecological Pathology, 2017
- Recurrent BCOR Internal Tandem Duplication and YWHAE-NUTM2B Fusions in Soft Tissue Undifferentiated Round Cell Sarcoma of InfancyAmerican Journal of Surgical Pathology, 2016
- The clinical phenotype of YWHAE‐NUTM2B/E positive pediatric clear cell sarcoma of the kidneyGenes, Chromosomes and Cancer, 2015